Christopher A. Viehbacher
President And Chief Executive Officer
Biogen Inc. · BIIB
$23.6M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A filed April 28, 2026. Prior years are from that filing's three-year table.
Catalog as of September 15, 2026. Not a live market feed.
- Salary
- $1.7M
- Stock Awards
- $18.4M
- Incentives
- $3.2M
- Other
- $358K
Compensation History
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,727,885 | $18,368,875 | $23,646,004 |
| 2024 | $1,600,000 | $18,010,911 | $24,166,665 |
| 2023 | $1,600,000 | $0 | $4,069,913 |
Current Position
- Company
- Biogen Inc.
- Title
- President And Chief Executive Officer
- Ticker
- BIIB · NASDAQ
- Fiscal Year
- 2025
SEC Sources
Fiscal years below are columns from the latest DEF 14A Summary Compensation Table (filed April 28, 2026), not separate historical filings.
| Fiscal Year | Source |
|---|---|
| 2025 | View SEC filing |
| 2024 | View SEC filing |
| 2023 | View SEC filing |
Accession 0001193125-26-187303.
Other Biogen Executives
Robin C. Kramer
Executive Vice President And Chief Financial Officer
Biogen · BIIB
$5.8M
FY 2025 · DEF 14A
Susan H. Alexander
Executive Vice President, Chief Legal Officer
Biogen · BIIB
$8.1M
FY 2025 · DEF 14A
Priya A. Singhal
Head Of Development
Biogen · BIIB
$7.6M
FY 2025 · DEF 14A
Nicole C. Murphy
Head Of Pharmaceutical Operations And Technology
Biogen · BIIB
$7.6M
FY 2025 · DEF 14A
Michael R. McDonnell
Former Executive Vice President And Chief Financial Officer
Biogen · BIIB
$271K
FY 2025 · DEF 14A